State Street Corp Annexon, Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Annexon, Inc. stock. As of the latest transaction made, State Street Corp holds 1,980,984 shares of ANNX stock, worth $4.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,980,984

Previous 2,039,826 2.88%

Holding current value

$4.83 Million

Previous $3.94 Million 20.78%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.38 - $2.73 $81,201 - $160,638	-58,842 Reduced 2.88%	1,980,984 $4.75 Million
Q1 2025 May 15, 2025	SELL	$1.93 - $5.5 $4.77 Million - $13.6 Million	-2,470,888 Reduced 54.78%	2,039,826 $3.94 Million
Q4 2024 Feb 14, 2025	BUY	$4.44 - $7.63 $2.97 Million - $5.1 Million	668,835 Added 17.41%	4,510,714 $23.1 Million
Q3 2024 Nov 14, 2024	BUY	$4.49 - $7.2 $9.29 Million - $14.9 Million	2,068,294 Added 116.62%	3,841,879 $22.7 Million
Q2 2024 Aug 14, 2024	BUY	$4.33 - $6.79 $2.49 Million - $3.91 Million	575,462 Added 48.03%	1,773,585 $8.69 Million
Q1 2024 May 15, 2024	BUY	$4.03 - $7.81 $1.42 Million - $2.75 Million	351,849 Added 41.58%	1,198,123 $8.59 Million
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $24,009 - $68,199	14,730 Added 1.77%	846,274 $3.84 Million
Q3 2023 Nov 14, 2023	BUY	$2.13 - $3.84 $79,449 - $143,232	37,300 Added 4.7%	831,544 $1.96 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $1.34 Million - $4.07 Million	638,445 Added 409.79%	794,244 $2.8 Million
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $120,802 - $240,958	32,300 Added 26.15%	155,799 $599,000
Q4 2022 Feb 14, 2023	BUY	$4.56 - $6.61 $131,601 - $190,764	28,860 Added 30.49%	123,499 $638,000
Q3 2022 Nov 15, 2022	BUY	$3.75 - $6.63 $21,750 - $38,454	5,800 Added 6.53%	94,639 $585,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $4.06 $986,013 - $1.9 Million	-467,305 Reduced 84.03%	88,839 $335,000
Q1 2022 May 16, 2022	SELL	$2.73 - $11.94 $2.01 Million - $8.81 Million	-738,038 Reduced 57.03%	556,144 $1.52 Million
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $9.07 Million - $17.4 Million	789,539 Added 156.45%	1,294,182 $14.9 Million
Q3 2021 Nov 15, 2021	SELL	$16.35 - $23.4 $7.06 Million - $10.1 Million	-432,027 Reduced 46.12%	504,643 $9.39 Million
Q2 2021 Aug 16, 2021	BUY	$17.81 - $27.48 $3.18 Million - $4.91 Million	178,578 Added 23.56%	936,670 $21.1 Million
Q1 2021 May 17, 2021	BUY	$22.0 - $35.01 $11 Million - $17.5 Million	499,198 Added 192.82%	758,092 $21.1 Million
Q4 2020 Feb 16, 2021	BUY	$20.81 - $30.55 $1.6 Million - $2.36 Million	77,116 Added 42.42%	258,894 $6.48 Million
Q3 2020 Nov 10, 2020	BUY	$17.5 - $30.23 $3.18 Million - $5.5 Million	181,778 New	181,778 $5.5 Million

Others Institutions Holding ANNX

# of Institutions

136

Shares Held

96.3M

Call Options Held

Put Options Held

63.4K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $116M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Annexon, Inc. Transaction History